triphenyltetrazolium has been researched along with Encephalitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lee, H; Swanson, RA; Tang, XN; van Hoecke, M; Wang, Q; Yenari, MA; Zheng, Z | 1 |
Han, IO; Hwang, JS; Hwang, SY; Kim, JB; Kim, SY; Lee, JK; Oh, ES; Oh, S; Shin, JA; Shin, JH | 1 |
2 other study(ies) available for triphenyltetrazolium and Encephalitis
Article | Year |
---|---|
Pyruvate protects against experimental stroke via an anti-inflammatory mechanism.
Topics: Animals; Body Weight; Cell Count; Disease Models, Animal; Ectodysplasins; Encephalitis; Infarction, Middle Cerebral Artery; Lactic Acid; Lipopolysaccharides; Male; Matrix Metalloproteinase 9; Microglia; Motor Activity; Nervous System Diseases; Neutrophil Infiltration; NF-kappaB-Inducing Kinase; Protein Serine-Threonine Kinases; Psychomotor Performance; Pyruvic Acid; Rats; Rats, Sprague-Dawley; Tetrazolium Salts | 2009 |
Glucosamine exerts a neuroprotective effect via suppression of inflammation in rat brain ischemia/reperfusion injury.
Topics: Animals; Brain Infarction; Cell Line, Transformed; Cell Survival; Chromatin Immunoprecipitation; Disease Models, Animal; Electrophoretic Mobility Shift Assay; Encephalitis; Enzyme Inhibitors; Gene Expression Regulation; Glucosamine; Infarction, Middle Cerebral Artery; Lipopolysaccharides; Male; Mice; Microglia; Neuroprotective Agents; NF-kappa B; Rats; RNA, Messenger; Severity of Illness Index; Tetrazolium Salts; Transfection | 2010 |